TY - JOUR
T1 - The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells
T2 - Implications for COVID-19 vascular research
AU - Muhl, Lars
AU - He, Liqun
AU - Sun, Ying
AU - Andaloussi Mäe, Maarja
AU - Pietilä, Riikka
AU - Liu, Jianping
AU - Genové, Guillem
AU - Zhang, Lei
AU - Xie, Yuan
AU - Leptidis, Stefanos
AU - Mocci, Giuseppe
AU - Stritt, Simon
AU - Osman, Ahmed
AU - Anisimov, Andrey
AU - Hemanthakumar, Karthik Amudhala
AU - Räsänen, Markus
AU - Hansson, Emil M.
AU - Björkegren, Johan
AU - Vanlandewijck, Michael
AU - Blomgren, Klas
AU - Mäkinen, Taija
AU - Peng, Xiao Rong
AU - Hu, Yizhou
AU - Ernfors, Patrik
AU - Arnold, Thomas D.
AU - Alitalo, Kari
AU - Lendahl, Urban
AU - Betsholtz, Christer
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2022/5/10
Y1 - 2022/5/10
N2 - Humanized mouse models and mouse-adapted SARS-CoV-2 virus are increasingly used to study COVID-19 pathogenesis, so it is important to learn where the SARS-CoV-2 receptor ACE2 is expressed. Here we mapped ACE2 expression during mouse postnatal development and in adulthood. Pericytes in the CNS, heart, and pancreas express ACE2 strongly, as do perineurial and adrenal fibroblasts, whereas endothelial cells do not at any location analyzed. In a number of other organs, pericytes do not express ACE2, including in the lung where ACE2 instead is expressed in bronchial epithelium and alveolar type II cells. The onset of ACE2 expression is organ specific: in bronchial epithelium already at birth, in brain pericytes before, and in heart pericytes after postnatal day 10.5. Establishing the vascular localization of ACE2 expression is central to correctly interpret data from modeling COVID-19 in the mouse and may shed light on the cause of vascular COVID-19 complications.
AB - Humanized mouse models and mouse-adapted SARS-CoV-2 virus are increasingly used to study COVID-19 pathogenesis, so it is important to learn where the SARS-CoV-2 receptor ACE2 is expressed. Here we mapped ACE2 expression during mouse postnatal development and in adulthood. Pericytes in the CNS, heart, and pancreas express ACE2 strongly, as do perineurial and adrenal fibroblasts, whereas endothelial cells do not at any location analyzed. In a number of other organs, pericytes do not express ACE2, including in the lung where ACE2 instead is expressed in bronchial epithelium and alveolar type II cells. The onset of ACE2 expression is organ specific: in bronchial epithelium already at birth, in brain pericytes before, and in heart pericytes after postnatal day 10.5. Establishing the vascular localization of ACE2 expression is central to correctly interpret data from modeling COVID-19 in the mouse and may shed light on the cause of vascular COVID-19 complications.
KW - Angiotensin converting enzyme 2 (ACE2)
KW - COVID-19
KW - Endothelial Cells
KW - SARS-CoV-2
KW - Vasculature
KW - pericytes
KW - single-cell RNA-sequencing
UR - http://www.scopus.com/inward/record.url?scp=85129684356&partnerID=8YFLogxK
U2 - 10.1016/j.stemcr.2022.03.016
DO - 10.1016/j.stemcr.2022.03.016
M3 - Article
C2 - 35452595
AN - SCOPUS:85129684356
SN - 2213-6711
VL - 17
SP - 1089
EP - 1104
JO - Stem Cell Reports
JF - Stem Cell Reports
IS - 5
ER -